February 11, 2026 – Thermo Fisher Scientific introduced a strategic knowledge partnership with Datavant, the info collaboration platform trusted for healthcare, to make it simpler for pharmaceutical and biotech firms to attach real-world knowledge with medical analysis, serving to them generate stronger proof sooner. Thermo Fisher’s PPD™ medical analysis operations and Datavant will allow safe connection and evaluation of real-world knowledge (RWD), together with RWD enrichment of randomized medical trials, PPD™ CorEvitas™ Medical Registries and PPD™ Evidera™ options.

Datavant allows privacy-preserving tokenization and linking of patient-level knowledge throughout greater than 350 RWD companions and 80,000 U.S. hospitals and clinics. This expertise permits Thermo Fisher’s medical PPD analysis enterprise to securely join anonymized analysis datasets and retrieve authorized digital medical file (EMR) knowledge for personalized RWD era. Integrating Datavant’s encrypted token expertise inside Thermo Fisher’s RWD infrastructure will present biopharma and biotech prospects with entry to enhanced linked affected person knowledge and superior analytics to design extra related trials, enhance recruitment and speed up proof era, in the end supporting higher affected person outcomes.

The partnership builds on Thermo Fisher’s broader investments in digital innovation, together with its strategic partnership with OpenAI, to ship larger worth and larger scientific innovation to life sciences prospects.

Proceed studying